Next report date
Report period
Q1 2024
EPS estimate
−0.14USD
Revenue estimate
47.07 MUSD
−78.02 MUSD
175.51 MUSD
127.86 M
Om Aurinia Pharmaceuticals Inc
Sektor
Bransch
VD
Peter S. Greenleaf
Webbplats
Huvudkvarter
Edmonton
Employees (FY)
300
Grundat
1993
FIGI
BBG000BCRJM5
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
